2[2]Sasayama S, Matsumori A, Matoba Y. Immunomodulation:a new horizon for medical treatment of hearfailure. J Card Fail,1996; 2 (4 Suppl): S287
3[3]Sasayama S, Matsumori A. Vesnarinone: a potential cytokine inhibitor. J Card Fail, 1996;2(3):251
4[4]Matsumori A, Sasayama S. Immunomodulating agents for the management of heart failure with myocarditis and cardiomy opathy lessons from animal experiments. Eur Heart J, 1995;16SupplO: 140
5[5]Matsumori A. Cytokines in myocarditis and cardiomyopathies. Curr Opin Cardiol, 1996; 11 (3): 302
6[6]Sato Y, Matsumori A, Sasayama S, et al. Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbiliced vein endothilial cells. J Mol Cell Cardiol, 1995; 27(1 ): 2265
7[7]Oyaizu N, McCloskey TW, Than S. Inhibition of CD4Cross-linking-induced lymphocytes apoptosis by resnarinone as a novel immunomodulating gent: vesnarinone inhibitis Fas expression and apoptosis by blocking cytokine secretion. Blood, 1996;87(6) :2361
